DK1644045T3 - Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle - Google Patents

Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle

Info

Publication number
DK1644045T3
DK1644045T3 DK04743927T DK04743927T DK1644045T3 DK 1644045 T3 DK1644045 T3 DK 1644045T3 DK 04743927 T DK04743927 T DK 04743927T DK 04743927 T DK04743927 T DK 04743927T DK 1644045 T3 DK1644045 T3 DK 1644045T3
Authority
DK
Denmark
Prior art keywords
interest
molecule
transferring
vehicle
pathogenic
Prior art date
Application number
DK04743927T
Other languages
Danish (da)
English (en)
Inventor
Irene Tatischeff
Annette Alfsen
Francoise Lavialle
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of DK1644045T3 publication Critical patent/DK1644045T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inert Electrodes (AREA)
DK04743927T 2003-07-15 2004-07-13 Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle DK1644045T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291752A EP1498144A1 (fr) 2003-07-15 2003-07-15 Vésicules extracellulaires d' amibes non pathogènes utiles pour transférer une molécule d' intérêt dans une cellule eucaryote
PCT/IB2004/002265 WO2005004925A1 (fr) 2003-07-15 2004-07-13 Vesicules extracellulaires provenant d'amibes non pathogenes utilse comme vehicules pour le transfert d'une molecule d'interet therapeutique dans une cellule eucaryote

Publications (1)

Publication Number Publication Date
DK1644045T3 true DK1644045T3 (da) 2009-12-14

Family

ID=33462243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04743927T DK1644045T3 (da) 2003-07-15 2004-07-13 Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle

Country Status (8)

Country Link
US (2) US7722855B2 (fr)
EP (2) EP1498144A1 (fr)
AT (1) ATE439865T1 (fr)
CA (1) CA2531865C (fr)
DE (1) DE602004022676D1 (fr)
DK (1) DK1644045T3 (fr)
ES (1) ES2331884T3 (fr)
WO (1) WO2005004925A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107949B2 (en) * 1996-11-12 2015-08-18 The University Of Akron Method for using naturally occurring gas vesicles as ultrasound contrast agent
EP2245199B1 (fr) * 2008-02-01 2013-11-13 The General Hospital Corporation Utilisation de microvésicules dans le diagnostic, le pronostic et le traitement de maladies et d affections médicales
WO2011109440A1 (fr) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarqueurs pour théranostique
BR112012001077A2 (pt) * 2009-07-16 2020-08-11 The General Hospital Corporation extração de ácido nucleico, métodos para avaliar a qualidade de uma extração de ácido nucleico e de uma amostra biológica, para ober ácido nucleico a partir de uma amostra biológica, para analisar rna de microvesículas e para diagnosticar e monitorar um indivíduo, e, kit
WO2011027956A2 (fr) * 2009-09-04 2011-03-10 주식회사이언메딕스 Vésicules extracellulaires issues de bactéries à gram positif, et modèle de maladie utilisant celles-ci
CN102480932B (zh) 2009-09-01 2015-01-14 阿昂梅迪克斯公司 源于肠道共生细菌的细胞外小泡及利用其的疫苗、备选药物筛选方法
EP2475989A4 (fr) 2009-09-09 2013-02-27 Gen Hospital Corp Utilisation de microvésicules dans l'analyse de mutations kras
WO2011031877A1 (fr) 2009-09-09 2011-03-17 The General Hospital Corporation Utilisation de microvésicules dans l'analyse de profils d'acide nucléique
WO2011097480A1 (fr) * 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Compositions exosomales et procédés pour le traitement de maladies
WO2011127219A1 (fr) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Biomarqueurs circulants pour une maladie
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
JP6219721B2 (ja) 2010-11-10 2017-10-25 エキソソーム ダイアグノスティックス インコーポレイテッド 核酸含有粒子の単離および該粒子からの核酸の抽出のための方法
WO2018034457A1 (fr) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 Composition permettant de prévenir ou de traiter un trouble mental, contenant une vésicule dérivée de bactéries d'une espèce lactobacillus
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2018034430A1 (fr) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 Composition pour prévenir ou traiter un trouble mental, contenant une vésicule dérivée de lactobacillus plantarum
MX2016014875A (es) * 2016-11-11 2018-05-10 Centro De Investig Y De Estudios Avanzados Del I P N Vesiculas extracelulares gigantes inmunogenicas de protozoos parasitos y metodos para su induccion y purificacion.
GB201702863D0 (en) * 2017-02-22 2017-04-05 Evox Therapeutics Ltd Improved loading of EVs with therapeutic proteins
CN115433684A (zh) * 2022-10-20 2022-12-06 云南师范大学 一种盘基网柄菌细胞同步化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same

Also Published As

Publication number Publication date
ES2331884T3 (es) 2010-01-19
EP1644045B1 (fr) 2009-08-19
EP1498144A1 (fr) 2005-01-19
US7722855B2 (en) 2010-05-25
CA2531865A1 (fr) 2005-01-20
US20070104738A1 (en) 2007-05-10
US7790196B2 (en) 2010-09-07
US20100178702A1 (en) 2010-07-15
CA2531865C (fr) 2012-12-04
DE602004022676D1 (de) 2009-10-01
WO2005004925A1 (fr) 2005-01-20
ATE439865T1 (de) 2009-09-15
EP1644045A1 (fr) 2006-04-12

Similar Documents

Publication Publication Date Title
DK1644045T3 (da) Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle
WO2010042516A3 (fr) Système et procédé de cartographie d’itinéraire
CY1110491T1 (el) Διαμορφωτες του υποδοχεα γλυκοκορτικοειδους αζαδεκαλινης
ATE377947T1 (de) Capsaicinderivate und deren produktion und verwendung
ATE470857T1 (de) Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität
GB0500655D0 (en) Improvements in or relating to network mobility
WO2005003086A3 (fr) Derives sulfonamide de colorants polycycliques pour applications analytiques
WO2009065508A3 (fr) Colorants de rylènes solubles dans l'eau, leurs procédés de préparation et leurs utilisations en tant que marqueurs fluorescents pour des biomolécules
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
WO2007019517A3 (fr) Procede d'analyse de gaz
DK1685247T3 (da) Vektorer til retningsbestemt kloning
WO2008140582A3 (fr) Production de peptides anti-microbiens
ECSP088519A (es) Metodos para preparar rapamicina cristalina y para medir la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido
WO2007062151A3 (fr) Composes chimiques
WO2007062148A3 (fr) Composes chimiques
WO2009020430A8 (fr) Procédé de formation d'un nanocristal contenant du cadmium
NO20072071L (no) Flytende modulkonstruksjon
WO2007062145A3 (fr) Composes chimiques
WO2007062190A3 (fr) Composes chimiques
WO2005041368A9 (fr) Nouveau laser a hydrogene moleculaire gazeux
ATE524482T1 (de) Ionische flüssigkeiten mit niedriger viskosität
MX2007015972A (es) Preparacion de levadura liquida estabilizada y metodo para su produccion y uso.
WO2007004092A3 (fr) Nouveaux intermediaires, processus destine a leur preparation et processus de preparation de coq10 utilisant lesdits nouveaux intermediaires
EP1785482A4 (fr) Procede de selection de cellules myocardiques en utilisant des mitochondries intracellulaires comme indice
ATE410485T1 (de) Härtbare farbige zusammensetzung, farbfilter und verfahren zu deren herstellung